Your search returned 11 results.

Results
	1.	Tumor-primed, in vitro-activated CD4+ effector T cells establish long-term memory without exogenous cytokine support or ongoing antigen exposure. [electronic resource] by Wang, Li-Xin Plautz, Gregory E Producer: 20100719 In: Journal of immunology (Baltimore, Md. : 1950) vol. 184 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	T cells sensitized with breast tumor progenitor cell vaccine have therapeutic activity against spontaneous HER2/neu tumors. [electronic resource] by Wang, Li-Xin Plautz, Gregory E Producer: 20121119 In: Breast cancer research and treatment vol. 134 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Considerations on clinical use of T cell immunotherapy for cancer. [electronic resource] by Plautz, Gregory E Cohen, Peter A Shu, Suyu Producer: 20031112 In: Archivum immunologiae et therapiae experimentalis vol. 51 Availability: No items available. Save to lists Add to cart (remove)
	4.	Host lymphodepletion augments T cell adoptive immunotherapy through enhanced intratumoral proliferation of effector cells. [electronic resource] by Wang, Li-Xin Shu, Suyu Plautz, Gregory E Producer: 20051219 In: Cancer research vol. 65 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Adoptive immunotherapy of advanced tumors with CD62 L-selectin(low) tumor-sensitized T lymphocytes following ex vivo hyperexpansion. [electronic resource] by Wang, Li-Xin Chen, Bing-Guan Plautz, Gregory E Producer: 20021023 In: Journal of immunology (Baltimore, Md. : 1950) vol. 169 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Adoptive transfer of tumor-primed, in vitro-activated, CD4+ T effector cells (TEs) combined with CD8+ TEs provides intratumoral TE proliferation and synergistic antitumor response. [electronic resource] by Wang, Li-Xin Shu, Suyu Disis, Mary L Plautz, Gregory E Producer: 20070702 In: Blood vol. 109 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Active immunotherapy for advanced intracranial murine tumors by using dendritic cell-tumor cell fusion vaccines. [electronic resource] by Kjaergaard, Jorgen Wang, Li-Xin Kuriyama, Hideyuki Shu, Suyu Plautz, Gregory E Producer: 20050920 In: Journal of neurosurgery vol. 103 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Memory T cells originate from adoptively transferred effectors and reconstituting host cells after sequential lymphodepletion and adoptive immunotherapy. [electronic resource] by Wang, Li-Xin Kjaergaard, Jorgen Cohen, Peter A Shu, Suyu Plautz, Gregory E Producer: 20040713 In: Journal of immunology (Baltimore, Md. : 1950) vol. 172 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Tumor-induced L-selectinhigh suppressor T cells mediate potent effector T cell blockade and cause failure of otherwise curative adoptive immunotherapy. [electronic resource] by Peng, Liaomin Kjaergäard, Jørgen Plautz, Gregory E Awad, Mohamed Drazba, Judith A Shu, Suyu Cohen, Peter A Producer: 20021210 In: Journal of immunology (Baltimore, Md. : 1950) vol. 169 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Adoptive immunotherapy of cancer with polyclonal, 108-fold hyperexpanded, CD4+ and CD8+ T cells. [electronic resource] by Wang, Li-Xin Huang, Wen-Xin Graor, Hallie Cohen, Peter A Kim, Julian A Shu, Suyu Plautz, Gregory E Publication details: Journal of translational medicine Nov 2004 In: Journal of translational medicine vol. 2 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	Mechanism of third signals provided by IL-12 and OX-40R ligation in eliciting therapeutic immunity following dendritic-tumor fusion vaccination. [electronic resource] by Kuriyama, Hideyuki Watanabe, Satoshi Kjaergaard, Jorgen Tamai, Hidemasa Zheng, Rongxiu Weinberg, Andrew D Hu, Hong-Ming Cohen, Peter A Plautz, Gregory E Shu, Suyu Producer: 20070508 In: Cellular immunology vol. 243 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)